H.R. 5957 · 118th Congress (2023–2025)
Robin Danielson Menstrual Product and Intimate Care Product Safety Act of 2023
This bill requires the National Institutes of Health to conduct or support research on the extent to which components (including contaminants and substances used as fragrances, colorants, dyes, and preservatives) in menstrual products and intimate care products pose health risks to people who use the products or to the children of people who use the products during or before pregnancy.
Show official title
To amend the Public Health Service Act to establish a program of research regarding the risks posed by the presence of dioxins, phthalates, pesticides, chemical fragrances, and other components of menstrual products and intimate care products.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to Health
This bill’s path
This is H.R. 5957’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. Grace Meng (D-NY-6)
- Cosponsors
14 cosponsors
6 original · 8 later
14 D
- Rep. Judy Chu (D-CA-28)· Original · Oct 13, 2023
- Rep. Jasmine Crockett (D-TX-30)· Original · Oct 13, 2023
- Rep. Ro Khanna (D-CA-17)· Original · Oct 13, 2023
- Rep. Gwen Moore (D-WI-4)· Original · Oct 13, 2023
- Rep. Janice D. Schakowsky (D-IL-9)· Original · Oct 13, 2023
- Rep. Bonnie Watson Coleman (D-NJ-12)· Original · Oct 13, 2023
- Rep. Alma S. Adams (D-NC-12)· Later · Oct 17, 2023
- Rep. Sheila Cherfilus-McCormick (D-FL-20)· Later · Oct 17, 2023
- Rep. Nanette Diaz Barragán (D-CA-44)· Later · Oct 30, 2023
- Rep. Yvette D. Clarke (D-NY-9)· Later · Oct 30, 2023
- Rep. Nydia M. Velázquez (D-NY-7)· Later · Oct 30, 2023
- Rep. Steve Cohen (D-TN-9)· Later · Feb 6, 2024
- Rep. Marie Gluesenkamp Perez (D-WA-3)· Later · Feb 28, 2024
- Rep. Rashida Tlaib (D-MI-12)· Later · Jun 25, 2024
- Policy area
- Health
- Subjects
- Child health
- Hazardous wastes and toxic substances
- Medical research
- Research administration and funding
- Sex and reproductive health
- Women's health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 2 committee actions · Oct 25, 2023 – Nov 3, 2023
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Expired
Introduced → Referred to House Health → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Robin Danielson Menstrual Product and Intimate Care Product Safety Act of 2023
Display title, Short title · Introduced in House
To amend the Public Health Service Act to establish a program of research regarding the risks posed by the presence of dioxins, phthalates, pesticides, chemical fragrances, and other components of menstrual products and intimate care products.
Official title · Introduced in House